Abstracts Archive

Introduction:HSTCL is a rare, aggressive extranodal lymphoma which primarily affects adolescents and young adults. A substantial subset occurs in immunosuppressed patients. Objectives:Given the scarcity of large-scale data, we performed a pooled analysis to define clinical features, outcomes, a...

Background:Patients who progress with Cutaneous T-Cell Lymphoma (CTCL) often experience a life marred by pruritus and chronic skin involvement which negatively impacts their quality of life (QoL). In this study, we described racial and clinical disparities in patterns of care in CTCL in a single cen...

Cutaneous T-cell lymphomas (CTCL) are a rare and heterogeneous group of non-Hodgkin lymphomas that primarily affect the skin. Given the rarity of CTCL and the limited number of treatment options available, clear, accessible, and high-quality patient education is essential to support informed decisio...

Introduction: Sézary syndrome (SS) is a rare, aggressive leukemic cutaneous T-cell lymphoma with historically poorer outcomes in Black patients.Objective: To evaluate racial and sex-based survival disparities in SS.Methods: 75 SS cases at Moffitt Cancer Center (MCC, 2015–2025) and ...

Introduction: The real-world treatment patterns and prognosis of patients with R/R mature T-cell and natural killer-cell lymphoma (MTNKL) in this new treatment era remains unclear. Objectives: We elucidated second-line (2L) therapy outcomes and treatment patterns for R/R MTNKL.Methods: This mul...

Introduction: Racial disparities in cutaneous T-cell lymphoma (CTCL) outcomes persist, with Black patients experiencing higher mortality. While novel agents like mogamulizumab and brentuximab vedotin improve survival, it remains unclear if differential access to these therapies contributes to outco...